SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001213900-19-008902
Filing Date
2019-05-15
Accepted
2019-05-15 17:27:35
Documents
7

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 11924
2 AMENDMENT NO. 2 TO POST-QUALIFICATION OFFERING CIRCULAR f1apos2019a2_emeraldhealth.htm PART II AND III 1159900
3 CONSENT OF DELOITTE & TOUCHE LLP f1apos2019a2ex11-1_emerald.htm EX1A-11 CONSENT 2370
4 GRAPHIC image_001.jpg GRAPHIC 7552
5 GRAPHIC image_002.jpg GRAPHIC 19237
6 GRAPHIC image_003.jpg GRAPHIC 24097
7 GRAPHIC image_004.jpg GRAPHIC 12037
  Complete submission text file 0001213900-19-008902.txt   1262497
Mailing Address 5910 PACIFIC CENTER BLVD SUITE 300, SAN DIEGO CA 92121
Business Address 5910 PACIFIC CENTER BLVD SUITE 300, SAN DIEGO CA 92121 (858) 352-0622
Emerald Health Pharmaceuticals Inc. (Filer) CIK: 0001700800 (see all company filings)

IRS No.: 820669961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 1-A/A | Act: 33 | File No.: 024-10810 | Film No.: 19829786
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1